Centre de Référence Maladies Rares

U1035 INSERM

Biotherapy of genetic diseases, inflammatory disorders and cancers (BMGIC)

FR: Biologie Fondamentale Appliquée à la Médecine

U1035Display navigation INSERM U1035! FR / EN

Jean-Max PASQUET

INSERM Research Directorhead of normal and leukemic hematopoietic stem cells (NLHSC), jean-max.pasquet@u-bordeaux.fr

BIOSKETCH

PUBMED

Born the 19 February 1966 (BRIVE, France

Qualification

2011

  • PhD supervisor approval

2008

  • Approval for radioprotection

1999

  • Approval for animals breeding and experimentation

1996

  • PhD in biochemistry and molecular biology (Sciences Biologique et Médicales)

1993

  • Master’s degree in Health-biology (Sciences Biologiques et Médicales)

Post-doctorate training

1997-1999

  • Department of Pharmacology, University of Oxford, UK (Team leader: Dr S Watson)

Teaching

From 2001

  • Master Degree « Biologie cellulaire et Physiopathologie » (4h), Université Bordeaux, (Oncogenèse et tyrosine kinases)

Expertise

  • Kinase signalling, proteomics, hematology, biochemistry, protein kinase, proteomics, pharmacology.
    Main field: leukemia

Evaluating activity

  • Member of the scientific board of the Canceropole GSO Axe 1’)
  • Member of the scientific and administrative board of the French Society of Hematology

Edition

  • Reviewer for the journals: Blood, Leukemia, Cancer Res, Oncogene, Mol Biol Cell, Mol Cancer Res, J Biol Chem, Exp Cell Res, J Mol Biol, Plos One.

+

  • Training: 3 PhD, 8 Masters, 3 post-doc
  • Invitational Conference
  • Publications: 47

Back to organigramme

INSERM U1035! - University of Bordeaux
Work
146 rue Léo Saignat - PE building south zone, 4th floor
33000 Bordeaux
Aquitaine
France
Work +33 557 57 13 73/74
sarah.lesjean@inserm.fr